Cargando…

Identifying predictors and evaluating the role of steroids in the prevention of post-embolization syndrome after transarterial chemoembolization and bland embolization

BACKGROUND: Transarterial chemoembolization (TACE) and bland embolization (TAE), performed for hepatocellular carcinoma (HCC), are often complicated by post-embolization syndrome (PES). There are limited data regarding the incidence of PES after TAE and the role of steroids in PES. We report the inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Rohit, Majeed, Muhammad, Aqeel, Sheeba-Ba, Wang, Yuchen, Haque, Zohaib, Omar, Yazan Abu, Upadhyay, Shristi Banskota, Gast, Thomas, Attar, Bashar M., Gandhi, Seema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903567/ https://www.ncbi.nlm.nih.gov/pubmed/33654366 http://dx.doi.org/10.20524/aog.2020.0566

Ejemplares similares

Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization
por: Lanza, Ezio, et al.
Publicado: (2020)

Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization
por: Chu, Hai-Jui, et al.
Publicado: (2015)

Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Comparison of transarterial bland embolization and drug-eluting beads transarterial chemoembolization for very early and early hepatocellular carcinoma not amenable for surgery or ablation: a single center retrospective data analysis
por: Cathomas, Marionna, et al.
Publicado: (2023)

Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Roth, Gaël S., et al.
Publicado: (2021)

Adrenocortical carcinoma with multiple liver metastases controlled by bland transarterial embolization and surgery resulting in long-term survival()
por: Watanabe, Kiichi, et al.
Publicado: (2022)

Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism
por: Liu, Jibing, et al.
Publicado: (2021)

Pulmonary air embolism associated with proximal bland thrombus
por: Morales-Cardenas, Adriana, et al.
Publicado: (2020)

Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
por: Ooka, Yoshihiko, et al.
Publicado: (2014)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
por: Guiu, Boris, et al.
Publicado: (2019)

Bland embolization of a ruptured hepatoblastoma with massive intraperitoneal hemorrhage
por: Nezami, Nariman, et al.
Publicado: (2020)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results
por: Hu, Shibing, et al.
Publicado: (2016)

Transarterial Chemoembolization-Induced Ischemic Colitis: A Rare Complication Due to Nontarget Embolization
por: Selzman, Jonathan, et al.
Publicado: (2023)

Combination Therapy of Bland Transarterial Embolization and Microwave Ablation for Hepatocellular Carcinoma within the Milan Criteria Leads to Significantly Higher Overall Survival
por: Adwan, Hamzah, et al.
Publicado: (2023)

Massive hepatic adenoma response to bland embolization: A case study
por: Sinkler, Margaret A., et al.
Publicado: (2018)

Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents
por: Chen, Shiguang, et al.
Publicado: (2018)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results: Erratum
Publicado: (2017)

Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: Impact of Embolic Density and Residual Tumor Perfusion on Tumor Recurrence and Survival
por: Ruff, Christer, et al.
Publicado: (2021)

Cholesterol crystal embolism in multiple organs after transarterial chemoembolization for hepatocellular carcinoma: An autopsy case report
por: Yamashita, Junki, et al.
Publicado: (2022)

Retrograde venous coil embolization prior to transarterial chemoembolization in hepatocellular carcinoma with arterio-hepatic venous shunts
por: Zhu, Wenliang, et al.
Publicado: (2022)

Safety and Efficacy of Infliximab in Severe Alcoholic Hepatitis: A Systematic Review
por: Majeed, Muhammad B, et al.
Publicado: (2019)

Bland Embolization of Benign Liver Tumors: Review of the Literature and a Single Center Experience
por: Crawford, Daniel, et al.
Publicado: (2021)

Large hepatic biloma after bland hepatic arterial embolization using antireflux catheter
por: Pham, Richard, et al.
Publicado: (2023)

Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
por: Bannangkoon, Kittipitch, et al.
Publicado: (2019)

Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma
por: Simasingha, Nitipon, et al.
Publicado: (2023)

Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis
por: Farooq, Muhammad Zain, et al.
Publicado: (2022)

Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial
por: Seinstra, Beatrijs A, et al.
Publicado: (2012)

Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels
por: Schicho, Andreas, et al.
Publicado: (2016)

Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization
por: Kim, Nam Hee, et al.
Publicado: (2019)

Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model
por: Abi-Jaoudeh, Nadine, et al.
Publicado: (2023)

Improving the results of transarterial embolization of type 2 endoleaks with the embolic polymer Onyx
por: Wojtaszek, Mikolaj, et al.
Publicado: (2016)

Transarterial embolization for management of severe postcoital bleeding
por: Eskandari, Armen, et al.
Publicado: (2016)

Transarterial Embolization of a Ruptured Renal Angiomyolipoma
por: Taki, Yasuhiro, et al.
Publicado: (2017)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
por: Furumaya, Alicia, et al.
Publicado: (2019)

Safety and efficacy of transarterial embolization of hepatocellular adenomas
por: van Rosmalen, B. V., et al.
Publicado: (2019)

Transarterial Embolization in Neonatal Kasabach–Merritt Syndrome
por: Wang, Yinghao, et al.
Publicado: (2021)

Transarterial Embolization of a Parasellar Hypervascular Tumor
por: Kiyosue, Hiro, et al.
Publicado: (2020)

Giant mediastinal neuroendocrine tumor successfully resected after transarterial chemoembolization of drug-eluting embolic microspheres: A case report
por: Yu, Qi, et al.
Publicado: (2021)

Rim Enhancement after Technically Successful Transarterial Chemoembolization in Hepatocellular Carcinoma: A Potential Mimic of Incomplete Embolization or Reactive Hyperemia?
por: Ekert, Kaspar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hedegd9scvrcosa0lhpm7hpc3f